Abstract
Background: Relapsed unresectable triple negative breast cancer is a demanding disease with currently no standard treatment option. Especially for patients with huge tumor masses a treatment that offers rapid tumour shrinkage is needed. Additionally, if several treatment lines had already been applied and patients are exhausted, systemic side effects have to be avoided.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
